Infection of human cells by an endogenous retrovirus of pigs

Nature Medicine

Volumn 3, Issue 3, 1997, Pages 282-286

  Patience, Clive ^a   Takeuchi, Yasuhiro ^a   Weiss, Robin A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENDOGENOUS VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SWINE; VIRUS INFECTION; XENOTRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; COCULTURE TECHNIQUES; GAMMARETROVIRUS; GENOME, VIRAL; HUMANS; KIDNEY; MOLECULAR SEQUENCE DATA; RETROVIRIDAE INFECTIONS; SWINE; TUMOR VIRUS INFECTIONS;

MUSTELA VISON; PIG ENDOGENOUS RETROVIRUS; SUS SCROFA; SUS SCROFA DOMESTICA; UNIDENTIFIED RETROVIRUS;

EID: 0031054438     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0397-282     Document Type: Article

References (10)

1. Institute of Medicine. Xenotransplantation, science, ethics and public policy. (National Academy Press, Washington DC, 1996).
2. Nuffield Council on Bioethics. Animal-to-human transplants: The ethics of xeno-transplantation. (London, 1996).
3. Gunsalus, J.R., Brady, D.A., Coulter, S.M., Gray, B.M. & Edge, A.S.B. Reduction of serum cholesterol in Watanabe rabbits by xenogenic hepatocellular transplantation. Nature Med. 3, 48-53 (1997).
4. Starzl, T.E. et al. Baboon-to-human liver transplantation. Lancet 341, 65-71 (1993).
5. Lehrman, S. AIDS patient given baboon bone marrow. Nature 378, 756 (1995).
6. Groth, C.G. et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344, 1402-1404 (1994).
7. Makowa, L. et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 59, 1654-1659 (1995).
8. Ryan, U.S. Complement inhibitory therapeutics and xenotransplantation. Nature Med. 1, 967-968 (1995).
9. Bach, F.H. et al. Barriers to xenotransplantation. Nature Med. 1, 869-873 (1995).
10. Sandrin, M.S. et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement mediated cytolysis. Nature Med. 1, 1261-1267 (1995).